psilocybin

change direction new plan alter arrows move reprioritize
Marketing

Cybin alters state to become Helus Pharma for Nasdaq trip

Cybin is shedding its old identity, evolving into Helus Pharma as part of changes that will see its shares move to a different stock exchange.
Nick Paul Taylor Dec 19, 2025 10:30am
Man on white background

Canadian company hopes to take psychedelic therapy mainstream

Jan 24, 2023 6:25am